Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

Affiliation auteurs!!!! Error affiliation !!!!
TitreLong-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia
Type de publicationJournal Article
Year of Publication2018
AuteursFeugier P, Aurran T, Mahe B, Letestu R, Nguyen-Khac F, Cazin B, Tournilhac O, Maisonneuve H, Casasnovas O, Delmer A, Leblond V, Royer B, Corront B, Chevret S, Delepine R, Vaudaux S, Van Den Neste E, Bene M-C, Cymbalista F, Ross-Weil D, Lepretre S
JournalHAEMATOLOGICA
Volume103
PaginationE304-E306
Date PublishedJUL 3
Type of ArticleLetter
ISSN0390-6078
DOI10.3324/haematol.2017.183350